| abstract |
The present invention relates to therapeutically active xanthine derivative compounds of Formula (I): n n n n n n n n n n corresponding processes for manufacture of said derivatives, pharmaceutical formulations containing and uses of such compounds in therapy, particularly in treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial. |